IL2 and cancer: Thus, the addition of ZOL to cultures of PBMC along with interleukin-2 (IL-2) leads to a selective expansion of Vγ9Vδ2 T cells, which are in turn highly efficacious killers of cancer cells upon sensitization of cancer cells with ZOL.